Investing Club: What increasing confidence in Biogen's latest Alzheimer's drug means for Eli Lilly
Wall Street increasingly believes U.S. drug regulators will approve Biogen 's latest experimental Alzheimer's treatment following the release of detailed late-stage clinical trial data. It's a development that may carry positive implications for Eli Lilly because the Club holding is investigating a similar drug targeting the disease.
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Wall Street increasingly believes U.S. drug regulators will approve
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focusAn experimental Alzheimer's drug slowed cognitive decline in a trial but may carry a risk of dangerous side effects for certain patients
Read more »
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focusThe 18-month trial enrolled nearly 1,800 participants.
Read more »
Rob Gronkowski says he'd 'whoop' Eli Manning at pickleball👀 RobGronkowski says he'd 'whoop' EliManning at pickleball.
Read more »
New Alzheimer’s Drug Shows Positive Results but Side EffectsA new Alzheimer’s drug slowed cognitive decline in a study, but caused brain bleeds and swelling in some patients, furthering debate about its usefulness
Read more »
New Alzheimer’s drug shows promise in slowing disease but may contain significant risks, study showsAn experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers report — but it remains unclear how much difference that might make in people’s lives.
Read more »
Former U-KISS member Eli to make a guest appearance on Channel S's variety show 'Attack on Sisters' | allkpopFormer U-KISS member Eli will be making a guest appearance on Channel S's variety show 'Attack on Sisters'.On November 30 KST, Channel S reveale…
Read more »